Pharma Journalist -

Pfizer Inc. and BioNTech SE  announced that the U.S. government has purchased 50 million more doses of the companies’ COVID-19 vaccine. The U.S. will receive these additional doses to…
Read More...

Takeda Pharmaceutical Company Limited announced the exercise of its option to acquire GammaDelta Therapeutics Limited (“GammaDelta”), a company focused on exploiting the unique…
Read More...

Sorrento Therapeutics, Inc. announced positive preliminary results from two Phase 2 studies designed to identify the hospitalized patient population suffering from COVID-19-induced…
Read More...

WuXi Biologics, a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP inspection by Health Canada for its drug substance…
Read More...

Signet Therapeutics and XtalPi Inc., a physics-based, AI-powered drug R&D company, announced the expansion of their AI drug discovery collaboration to include a new first-in-class…
Read More...

The Medicines Patent Pool (MPP) and Merck, known as MSD outside the United States and Canada, announced the signing of a voluntary licensing agreement to facilitate affordable global…
Read More...

Immunai, a New York-based biotech company, announced a $215M Series B, increasing the company’s total funding to date to $295M. The new capital will be used to expand Immunai’s “drug…
Read More...

Boehringer Ingelheim and Thoeris GmbH announce a collaboration and license agreement with the aim to investigate novel first-in-class therapies for patients with urea cycle disorders…
Read More...

Vertex Pharmaceuticals Incorporated and Mammoth Biosciences, a biotech company building the next generation of CRISPR products to cure and detect disease, today announced a new…
Read More...

Teva Pharmaceutical Industries Ltd. and MODAG GmbH announced a strategic collaboration on the exclusive worldwide licensing and development of MODAG's lead compound anle138b and a…
Read More...